346
Views
28
CrossRef citations to date
0
Altmetric
Original Articles

Biofilm-encapsulated nano drug delivery system for the treatment of colon cancer

, , , , , & show all
Pages 481-491 | Received 20 Nov 2019, Accepted 15 Jul 2020, Published online: 30 Jul 2020

References

  • Antonelli, A., et al., 2016. Characterization of ferucarbotran-loaded RBCs as long circulating magnetic contrast agents. Nanomedicine, 11 (21), 2781–2795.
  • Arbuck, S.G., 1989. Overview of clinical trials using 5-fluorouracil and leucovorin for the treatment of colorectal cancer. Cancer, 63 (S6), 1036–1044.
  • Bianco, P., et al., 2013. The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine. Nature medicine, 19 (1), 35–42.
  • Bose R.J.C., et al., 2016. Surface modification of polymeric nanoparticles with human adipose derived stem cell membranes AdMSCs. Proceedings of the World Biomaterials Congress.
  • Caley, A. and Jones, R., 2012. The principles of cancer treatment by chemotherapy. Surgery, 30 (4), 186–190.
  • Choi, M.R., et al., 2007. A cellular trojan horse for delivery of therapeutic nanoparticles into tumors. Nano letters, 7 (12), 3759–3765.
  • Dehaini, D., et al., 2017. Erythrocyte-platelet hybrid membrane coating for enhanced nanoparticle functionalization. Advanced materials, 29 (16), 1606209.
  • Desai, N., 2012. Challenges in development of nanoparticle-based therapeutics. The AAPS journal, 14 (2), 282–295.
  • Fang, R.H., Hu, C.-M.J., and Zhang, L., 2012. Nanoparticles disguised as red blood cells to evade the immune system. Expert opinion on biological therapy, 12 (4), 385–389.
  • Fisseha, M., et al., 2005. Characterization of native outer membrane vesicles from lpxL mutant strains of Neisseria meningitidis for use in parenteral vaccination. Infection and immunity, 73 (7), 4070–4080.
  • Gao, W., et al., 2015. Modulating antibacterial immunity via bacterial membrane-coated nanoparticles. Nano letters, 15 (2), 1403–1409.
  • Gao, W. and Zhang, L., 2015. Coating nanoparticles with cell membranes for targeted drug delivery. Journal of drug targeting, 23 (7–8), 619–626.
  • Gary-Bobo, M., et al., 2012. Hyaluronic acid-functionalized mesoporous silica nanoparticles for efficient photodynamic therapy of cancer cells. Photodiagnosis and photodynamic therapy, 9 (3), 256–260.
  • González, B., et al., 2018. Mesoporous silica nanoparticles decorated with polycationic dendrimers for infection treatment. Acta biomaterialia, 68, 261–271.
  • Govender, T., et al., 1999. PLGA nanoparticles prepared by nanoprecipitation: drug loading and release studies of a water soluble drug. Journal of controlled release, 57 (2), 171–185.
  • Grem, J.L., 2001. Biochemical modulation of 5-FU in systemic treatment of advanced colorectal cancer. Oncology, 15 (2), 13–19.
  • Hamidi, M. and Tajerzadeh, H., 2003. Carrier erythrocytes: an overview. Drug delivery, 10 (1), 9–20.
  • Hilgendorf, C., et al., 2015. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport. Journal of pharmaceutical sciences., 89 (1), 63–75.
  • Hu, C.M.J., et al., 2014. Polymeric nanotherapeutics: clinical development and advances in stealth functionalization strategies. Nanoscale, 6 (1), 65–75.
  • Hu, C.M., et al., 2012. Erythrocyte-inspired delivery systems. Advanced healthcare materials, 1 (5), 537–547.
  • Jambhrunkar, S., et al., 2014. Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicity. Molecular pharmaceutics, 11 (10), 3642–3655.
  • Jiang, F.Q., et al., 2015. Curative effect evaluation of microwave ablation combined with 5-fluorouracil intratumoral injection in treating colon cancer tumor-bearing mice. Journal of Hainan medical university, 21 (10), 1309–1311. +1315.
  • Kuipers, K., et al., 2015. Salmonella outer membrane vesicles displaying high densities of pneumococcal antigen at the surface offer protection against colonization. Vaccine, 33 (17), 2022–2029.
  • Lei, W., et al., 2019. Polydopamine-coated mesoporous silica nanoparticles for multi-responsive drug delivery and combined chemo-photothermal therapy. Materials science & engineering. C, materials for biological applications, 105, 110103.
  • Lv, Y.J., et al., 2017. Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles as hepatocellular carcinoma-targeted drug carrier. International journal of nanomedicine, 12, 4361–4370.
  • Oldenborg, P.A., et al., 2000. Role of CD47 as a marker of self on red blood cells. Science (new york, N.Y.), 288 (5473), 2051–2054.
  • Parodi, A., et al., 2013. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. Nature nanotechnology, 8 (1), 61–68.
  • Patel, R.P., et al., 2009. An overview of resealed erythrocyte drug delivery. Journal of pharmacy research, 2 (6), 1008–1012.
  • Roger, M., et al., 2010. Mesenchymal stem cells as cellular vehicles for delivery of nanoparticles to brain tumors. Biomaterials, 31 (32), 8393–8401.
  • Shao, L., et al., 2016. Mesoporous silica coated polydopamine functionalized reduced graphene oxide for synergistic targeted chemo-photothermal therapy. ACS applied materials & interfaces, 9 (2), 1226–1236.
  • Shao, M., et al., 2019. Polydopamine coated hollow mesoporous silica nanoparticles as pH-sensitive nanocarriers for overcoming multidrug resistance. Colloids and surfaces. B, biointerfaces, 183 (183), 110427
  • Park, S.S., et al., 2019. Functionalised mesoporous silica nanoparticles with excellent cytotoxicity against various cancer cells for pH-responsive and controlled drug delivery. Materials & design, 184, 108187.
  • Tan, S., et al., 2015. Cell or cell membrane-based drug delivery systems. Theranostics, 5 (8), 863–881.
  • Tang, K., et al., 2012. Delivery of chemotherapeutic drugs in tumour cell-derived microparticles. Nature communications, 3, 1282.
  • Tasleem, J.A., 2017. Outer membrane vesicles (OMVs) of Gram-negative bacteria: a perspective update. Frontiers in microbiology, 8, 1053.
  • Tian, X., et al., 2012. A membrane vesicle-based dual vaccine against melanoma and Lewis lung carcinoma. Biomaterials, 33 (26), 6147–6154.
  • Velusamy, P., et al., 2018. A pH stimuli thiol modified mesoporous silica nanoparticles: Doxorubicin carrier for cancer therapy. Journal of the Taiwan institute of chemical engineers, 87, 264–271.
  • Wang, W.D., et al., 2015. The relationship between biofilm and outer membrane vesicles: a novel therapy overview. FEMS microbiology letters, 362 (15), fnv117.
  • Yang, J.C., et al., 2017. Magnetic resonance imaging-guided multi-drug chemotherapy and photothermal synergistic therapy with pH and NIR-stimulation release. ACS applied materials & interfaces, 9 (27), 22278–22288.
  • Yu, C., et al., 2014. Inorganic nanoparticle-based drug codelivery nanosystems to overcome the multidrug resistance of cancer cells. Molecular pharmaceutics, 11 (8), 2495–2510.
  • Zhao, Q.F., et al., 2015. Dual-stimuli responsive hyaluronic acid-conjugated mesoporous silica for targeted delivery to CD44-overexpressing cancer cells. Acta biomaterialia, 23 (23), 147–156.
  • Zhou, H., et al., 2016. A facile approach to functionalize cell membrane-coated nanoparticles. Theranostics, 6 (7), 1012–1022.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.